Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Chinook Therapeutics Inc (KDNY)

Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,900,204
  • Shares Outstanding, K 71,805
  • Annual Sales, $ 6,130 K
  • Annual Income, $ -187,870 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.34
  • Price/Sales 472.22
  • Price/Cash Flow N/A
  • Price/Book 7.59
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.19
  • Most Recent Earnings $-0.94 on 08/07/23
  • Next Earnings Date 08/14/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.84
  • Number of Estimates 7
  • High Estimate -0.68
  • Low Estimate -1.03
  • Prior Year -0.83
  • Growth Rate Est. (year over year) -1.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.86 +3.94%
on 07/21/23
40.51 -0.30%
on 08/10/23
+1.29 (+3.30%)
since 07/10/23
3-Month
19.20 +110.36%
on 05/16/23
40.51 -0.30%
on 08/10/23
+17.26 (+74.62%)
since 05/10/23
52-Week
18.34 +120.23%
on 05/02/23
40.51 -0.30%
on 08/10/23
+19.88 (+96.93%)
since 08/10/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, NETI, TALS, QUOT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KDNY : 40.39 (+0.22%)
NETI : 11.33 (+0.09%)
TALS : 27.20 (-0.73%)
QUOT : 3.99 (unch)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...

KDNY : 40.39 (+0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, KDNY, AEL

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PRDS : 2.16 (unch)
KDNY : 40.39 (+0.22%)
AEL : 56.47 (+0.55%)
Moore Kuehn Encourages CWBR, KDNY, GHL, and DM Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

CWBR : 0.5400 (unch)
KDNY : 40.39 (+0.22%)
GHL : 14.99 (-0.13%)
DM : 2.85 (-8.06%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...

KDNY : 40.39 (+0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, WMC, IMNM, AJX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KDNY : 40.39 (+0.22%)
WMC : 9.18 (+4.44%)
IMNM : 10.97 (-0.99%)
AJX : 3.02 (-0.66%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates KDNY, FRG, ARNC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KDNY : 40.39 (+0.22%)
FRG : 29.88 (+0.10%)
ARNC : 29.99 (+0.03%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates FOCS, KDNY, PTEN, FRG

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FOCS : 52.99 (-0.02%)
KDNY : 40.39 (+0.22%)
PTEN : 7.68 (+5.35%)
FRG : 29.88 (+0.10%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...

KDNY : 40.39 (+0.22%)
Why Shares of Vera Therapeutics Jumped Tuesday

The company announced early phase 2 trials information regarding its lead therapy.

KDNY : 40.39 (+0.22%)
NVS : 97.11 (+0.35%)
VERA : 42.60 (+1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Chinook Therapeutics, Inc. is a clinical-stage biotechnology company. It focuses on developing precision medicines for kidney diseases. Chinook Therapeutics, Inc., formerly known as Aduro Biotech Inc., is based in BERKELEY, Calif.

See More

Key Turning Points

3rd Resistance Point 40.72
2nd Resistance Point 40.61
1st Resistance Point 40.50
Last Price 40.39
1st Support Level 40.29
2nd Support Level 40.18
3rd Support Level 40.07

See More

52-Week High 40.51
Last Price 40.39
Fibonacci 61.8% 32.04
Fibonacci 50% 29.42
Fibonacci 38.2% 26.81
52-Week Low 18.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar